These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25329665)

  • 1. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease.
    Park H; Shin JW; Park SG; Kim W
    PLoS One; 2014; 9(10):e109710. PubMed ID: 25329665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison Study of Oropharyngeal Microbiota in Case of Bronchial Asthma and Chronic Obstructive Pulmonary Disease in Different Severity Levels].
    Ogorodova LM; Fedosenko SV; Popenko AS; Petrov VA; Tyakht AV; Saltykova IV; Deev IA; Kulikov ES; Kirillova NA; Govorun VM; Kostryukova ES
    Vestn Ross Akad Med Nauk; 2015; (6):669-78. PubMed ID: 27093794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma.
    Lopes Dos Santos Santiago G; Brusselle G; Dauwe K; Deschaght P; Verhofstede C; Vaneechoutte D; Deschepper E; Jordens P; Joos G; Vaneechoutte M
    BMC Microbiol; 2017 May; 17(1):109. PubMed ID: 28486933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
    Einarsson GG; Comer DM; McIlreavey L; Parkhill J; Ennis M; Tunney MM; Elborn JS
    Thorax; 2016 Sep; 71(9):795-803. PubMed ID: 27146202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.
    Zakharkina T; Heinzel E; Koczulla RA; Greulich T; Rentz K; Pauling JK; Baumbach J; Herrmann M; Grünewald C; Dienemann H; von Müller L; Bals R
    PLoS One; 2013; 8(7):e68302. PubMed ID: 23874580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology.
    Larsen JM; Musavian HS; Butt TM; Ingvorsen C; Thysen AH; Brix S
    Immunology; 2015 Feb; 144(2):333-42. PubMed ID: 25179236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal microbial ecosystem perturbations influence the risk for acute respiratory infections in common variable immunodeficiency.
    Pulvirenti F; Giufrè M; Pentimalli TM; Camilli R; Milito C; Villa A; Sculco E; Cerquetti M; Pantosti A; Quinti I
    Front Immunol; 2024; 15():1371118. PubMed ID: 38873612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oropharyngeal microbiome profiling and its association with age and heart failure in the elderly population from the northernmost province of China.
    Liu J; He X-Y; Yang K-L; Zhao Y; Dai E-Y; Chen W-J; Raj AK; Li D; Zhuang M; Yin X-H; Ling H
    Microbiol Spectr; 2024 Oct; 12(10):e0021624. PubMed ID: 39162522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.
    Huang YJ; Kim E; Cox MJ; Brodie EL; Brown R; Wiener-Kronish JP; Lynch SV
    OMICS; 2010 Feb; 14(1):9-59. PubMed ID: 20141328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
    PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation induces a microbiota shift in sputa of COPD patients.
    Jubinville E; Veillette M; Milot J; Maltais F; Comeau AM; Levesque RC; Duchaine C
    PLoS One; 2018; 13(3):e0194355. PubMed ID: 29579057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characterization of bacterial communities of oropharynx microbiota in healthy children by combining culture techniques and sequencing of the 16S rRNA gene.
    Maleki A; Zamirnasta M; Taherikalani M; Pakzad I; Mohammadi J; Krutova M; Kouhsari E; Sadeghifard N
    Microb Pathog; 2020 Jun; 143():104115. PubMed ID: 32135220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saliva as a non-invasive specimen for COPD assessment.
    Melo-Dias S; Valente C; Andrade L; Marques A; Sousa A
    Respir Res; 2022 Jan; 23(1):16. PubMed ID: 35093093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 16. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
    Lee SW; Kuan CS; Wu LS; Weng JT
    PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.
    Pragman AA; Lyu T; Baller JA; Gould TJ; Kelly RF; Reilly CS; Isaacson RE; Wendt CH
    Microbiome; 2018 Jan; 6(1):7. PubMed ID: 29316977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.
    Wu X; Wei X; Li X; Deng J; Zhang J
    Jpn J Infect Dis; 2022 Nov; 75(6):560-568. PubMed ID: 35908874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice.
    Hilty M; Wüthrich TM; Godel A; Adelfio R; Aebi S; Burgener SS; Illgen-Wilcke B; Benarafa C
    Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33295863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Kou Z; Liu K; Qiao Z; Wang Y; Li Y; Li Y; Yu X; Han W
    Front Immunol; 2024; 15():1407439. PubMed ID: 38779669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.